Allergic granulomatous angioitis (Churg-Strauss syndrome, CSS) is a systemic vasculitis in patients with eosinophilia greater than 1.5x 10 911 and history of asthma. CSS is steroid responsive: asthma and eosinophilia improve rapidly and, usually, vasculitis requires no other immunosuppressive agents.
We report a case of CSS in whom the history of the syndrome and diagnosis were delayed by previous long-term therapy with steroids for severe asthma.
Journal of the Royal Society of Medicine Volume 83 October 1990 651 was nevertheless appropriate, the patient making a full recovery. Med 1984; 311:1144 -7 (Accepted 31 May 1990 We treated the patient with amoxicillin, theophilline, salbutamol and 75 mg daily of prednisolone, with rapid clinical improvement. The spirometric values and chest X-rays returned to normal.
The follow-up in outpatients was characterized by a general improvement and normal spirometric values with the gradual suspension of the steroids in 3 months. In the following 8 weeks asthenia and weight loss (7 kg) occurred, followed by migratory arthralgias, myalgias and subcutaneous nodules in the abdomen, forearms, knees and legs, and minimal broncospasm Other organs were not involved.
At two successive check-ups mild normocytic anaemia (Hb 10 g/dl), leukocytosis (13670/mm 3 ) with eosinophilia (33%: 5.6xl0 9 /l) were found. The biopsy of the nodules showed subcutaneous granulomas with multinucleated giant cells, epithelioid cells, lymphocytes and few eosinophils ( Figure 1 ). Prednisolone 60 mg daily was reintroduced bringing about a rapid improvement in general conditions and weight increase. Eosinophilia and subcutaneous nodules disappeared.
Case report
A 46-year-old woman was hospitalized with cough and severe wheezing. Her past history included perennial rhinitis and asthma from the age of 13 years. Skin prick tests for common inhalant allergens (including Aspergillus fumigatus) had been negative. In the previous 24 months she had been continually treated with 20-60 mg prednisolone daily for asthma.
A few hours before admission, she had received 500 mg of hydrocortisone intravenously; the spirometric values showed: FEV! (forced expiratory volume in one second) 1.48 litres (50%); FVC (forced vital capacity) 2.96 litres (82%); PEF (peak expiratory flow) 208 l/min (54%); FEV/FVC: 50%; laboratory findings demonstrated a raised erythrocyte sedimentation rate and leukocytosis with neutrophilia (18920/mm 3 , 93%).
Chest X-rays showed a diffuse interstitial infiltrative pattern and an infiltrate at the base of the right lung. 
Discussion
The natural history of CSS is characterized by three phases: the prodromal phase consisting of allergic disease can persist for years, even though not all patients have positive skin prick tests for common airborne allergens'. The eosinophilic phase is similar to the Leffler syndrome or to chronic eosinophilic pneumoniae. The final phase, systemic vasculitis, coincides with the disappearance of asthma in 58% of patients'. Eosinophilia is characteristic of this syndrome, however there are cases without eosinophilia because of previous steroid treatments for asthma.
Corticosteroids are potent and quick suppressors of peripheral eosinophilia and often dramatically improve the systemic vasculitis.
In our patient the prodromic phase lasted for more than 30 years. The second phase, probably coincided with the asthmatic steroid-dependent period. X-rays of this period showed a transient pulmonary infiltrate. Unfortunately, in Behcet's disease may cause severe systemic symptoms' and no specific therapy is available. Here is a case in which highdose intravenous gammaglobulin (lVIgG) associated with low-dose aspirin appeared to be efficacious.
Case report
A 28-year-old man presented with an 8-year history, beginning with mouth and scrotal ulcers. Later, phlebitic episodes occurred in winter. Independently, but apparently also related to cold, disabling ulcerations appeared in the left leg leading to prolonged hospitalization. For 4 years he was treated with colchicine and permanently with methylprednisolone. Thalidomide was also given briefly in 1987 at a dose of 400 mg per day on the occasion of recurrence of mouth and scrotal ulcers. In 1988, when being weaned off the corticoids, the leg ulcers increased in size and depth with associated exacerbation of congestion and oedema. This crisis was overcome by increasing the dose of corticoids and adding chlorambucil. Five months later, a partial improvement of the leg ulcers occurred when a 14-day highdose intravenous course of penicillin G (24 000 000 U/day) was given, concurrently with the other medication. Three attempts at autologous skin grafting were unsuccessful. The oozing ulcers were worsening and repeatedly required surgical removal of necrotic debris. During all that time the patient was on analgesics.
On readmission in May 1989, methylprednisolone (80 rng/day), chlorambucil (10 mg/day), colchicine (I mg/day) and penicillin G benzathine (2400000 units every 8 days) were stopped. IVIgG was started with 5 daily doses of 0.4 g per kg followed by reinforcement doses of 0.4 glkg at 2-week intervals. Aspirin was given as a daily dose of 0.25 g. An IgG-related side-effect, intense headache developed after the first two daily infusions, responding to intravenous dipyrone. Four days after beginning IgG therapy all four leg ulcers appeared dry. Analgesics could be discontinued some days later. Granulations appeared, reducing the ulcers in size, and this period, the total count of eosinophils never were steroidfree. Eight weeks after corticosteroids were suspended, eosinophilia and systemic vasculitis appeared.
We suggest that the administration of steroids for 27 months modified the natural course of the illness and lengthened the time of the diagnosis and that the incidence of CSS could be greater than is known; it is a matter of fact that steroids are potent suppressors of peripheral blood eosinophilia. An eosinophil count should always be done in patients with severe asthma before starting corticosteroid therapy, even in a clinical emergency.
Reference 1 Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 1984; 63:65-80 (Accepted 29 November 1989) 2 l h months later the patient became totally pain-free and walked without limping. The maximal erythrocyte sedimentation rate (ESR) improved remarkably from 110 to 20 mm (although, in our experience, high-dose IgG per se increases ESR). In spite of the winter season, no new episode of phlebitis developed. The toes of both feet were intermittently cyanotic but there were no trophic disturbances. After 3 months, one leg ulcer healed and new autologous skin grafts were attempted in the three larger ulcers. Although, during the initial 2 weeks they seemed to succeed, after the third week the grafts were rejected and the ulcers deepened. Microscopy of the border of an ulcer showed nonspecific oedema and neutrophils in the fibrin cover and infiltrating the dermis. Microvascular alterations were minimal when compared to the predominant vasculitis with mononuclear cell infiltration in the biopsy specimen of 1983. Graft failure on previous occasions was evident after 4 days. After the present rejection, the three remaining leg ulcers again improved and two months later the patient continued to be symptom free. Ten months later, the patient is in a stable condition with the same therapy.
Discussion
According to the 'tantalising glimpses of some aetiological factors":", Behcet's disease may be an autoimmune reaction set off by viral, bacterial, or other antigens. The condition is often palliated by immunosuppressants", including selective helper T-cells acting on cyclosporin highlighted by Masuda et al.3 IVIgG appears to be clinically beneficial in a variety of immune disorders. It may provide antibodies either acting directly against the triggering antigen or through the idiotypic network", or even by blocking Fe receptors", Interestingly, three cases of transient Behcet's disease were reported among neonates born to mothers with disease". Pregnancy in humans affords a valuable model for investigating the aetiology and pathogenesis of autoimmune disease". Women suffering from immunological diseases might be expected to 'transmit' transitorily symptoms of the disease to their offspring, with two provisos: (a) IgG type antibody must make a significant contribution to the pathophysiology of the disease and (b) fetal tissue must carry receptors for the antibody(s) concerned. It has been observed in autoimmune thrombocytopenia, Rh immunization, Grave's disease, and occurs in about 12% of the infants born to myastenic mothers", In these conditions high doses of IVIgG have been reported to be of benefit. In our case, aspirin was added to inhibit the platelet aggregator thromboxane in order to counteract the increased aggregability to which a decreased prostacyclin sensitivity of platelets seems to contribute in patients with Beheet's syndrome".
